Urodynamics: What to do and when is it clinically necessary? Matthew P. RutmanJerry G. Blaivas OriginalPaper 26 March 2008 Pages: 263 - 268
Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression Jonathan M. LevittKevin M. Slawin OriginalPaper 26 March 2008 Pages: 269 - 274
Hedgehog signaling in prostate growth and benign prostate hyperplasia Chad M. VezinaWade Bushman OriginalPaper 26 March 2008 Pages: 275 - 280
Risk factors for benign prostatic hyperplasia Steven J. Jacobsen OriginalPaper 26 March 2008 Pages: 281 - 288
Medical therapy versus surgery and minimally invasive surgical therapies for lower urinary tract symptoms and benign prostatic hyperplasia: What makes better economic sense? Mark D. StovskyKatherine RheeDavid Hartke OriginalPaper 26 March 2008 Pages: 289 - 297
Prostatitis: Updates on diagnostic evaluation Jason R. RothmanWilliam I. Jaffe OriginalPaper 26 March 2008 Pages: 301 - 306
Etiologic theories of chronic prostatitis/chronic pelvic pain syndrome Michel A. Pontari OriginalPaper 26 March 2008 Pages: 307 - 312
New therapies in chronic prostatitis Nivedita Bhatta DharDaniel A. Shoskes OriginalPaper 26 March 2008 Pages: 313 - 318
Review of adolescent urinary tract infection Mark HorowitzJacob Cohen OriginalPaper 26 March 2008 Pages: 319 - 323
Economic impact of chronic prostatitis Anna M. S. DuloyElizabeth A. CalhounJ. Quentin Clemens OriginalPaper 26 March 2008 Pages: 336 - 339